Pfizer Moves To Dismiss All 2,907 Lipitor Diabetes MDL Cases For Lack Of Experts

(June 28, 2016, 8:00 AM EDT) -- CHARLESTON, S.C. — Pfizer Inc. on June 24 filed an omnibus motion for summary judgment in all Lipitor diabetes cases in a multidistrict litigation in a South Carolina federal court (In Re: Lipitor [Atorvastatin Calcium] Marketing, Sales Practices and Products Liability Litigation, MDL Docket No. 2505, No. 14-mn-2502, D. S.C., Charleston Div.).

(Motion available. Document #28-160714-004M.)

In a motion filed in the U.S. District Court for the District of South Carolina, Pfizer and co-defendants Pfizer International Inc. and Greenstone LLC say the plaintiffs lack admissible general...
To view the full article, register now.